In a step forward in the development of genetic medicines, researchers have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification ...

The European Union on Tuesday approved the world’s first medicine based on CRISPR gene-editing technology to treat two blood disorders, following the U.S. and U.K. in a milestone for the revolutionary ...

In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have ...

Genetic medicines in development for blood disorders include several therapies made by taking a patient’s cells and editing them outside of the body. Novartis is one of the companies testing this ...

Please provide your email address to receive an email when new articles are posted on . Researchers at Children’s Hospital of Philadelphia and Perelman School of Medicine at University of Pennsylvania ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...

Researchers have used CRISPR gene editing -- a type of 'molecular scissors' -- to understand how deletions in one area of the genome can affect the expression of nearby genes. The work will help ...